In terms of digitization, the problems faced by many health care actors are vast, not only in the UK and Europe, but around the world. We have come to see mobile phones as something we can take everywhere with us through the power of homelessness. The same can not be said of the provision of wireless medical devices and networks, which could provide life-changing treatments for people, especially those with chronic conditions.
For example, in England, 15 million people suffer from long-term health problems, with their treatment absorbing 70% of the country's acute and primary care budgets. By 2018 the number of people with three or more long-term disorders is expected to reach 2.9 million, or an additional GBP 5 billion per year for the government.
In the United States, the Centers for Medicare and Medicaid Services (CMS) estimate that more than 68% of their beneficiaries suffer from at least two chronic diseases. It is also noted that 70% of deaths are caused by chronic illness.
Although the problem is real and technology is there to help solve it, the digital transformation of health care is not going away. Pilot projects have been launched in Europe and the United States, such as Qualcomm Life and TBS in the United Kingdom.
In the United States, Royal Philips and Banner Health, an Arizona company, showed a significant decrease in patient health care costs and hospitalization rates. The World Economic Forum has planned pilot programs in 2017 to show the interest of a new model of health care that would track and pay for treatment based on the quality of its operation rather than the volume of care.
Deployments on a Larger Scale Can not Be Found
"In Europe and other markets, there is increasing evidence of low scalability in digital health and care approaches, from pilot testing to large-scale deployment and Widespread adoption, "said Nathalie Vandystadt, spokesperson for the European Commission for the Digital Single Market. BDJ.
"Despite the recognized potential of the digital transformation of health and care providers and models of integrated, person-centered care, the benefits have not materialized in many cases, scale.
"Implementing such large-scale innovations to provide services to all citizens who can benefit from them is a major challenge.
"The technology itself is no longer the problem in this regard. Rather, it is about organizational issues such as the commitment of the authorities, the need to reconfigure services, designing new pathways for patients, new roles and skills of health and social service professionals, interoperability , protection of privacy and data, sustainable investments and new governance, contracting and payment methods. In addition, according to a report from the World Health Organization (2016), lack of funding is one of the biggest obstacles to deploying digital solutions for health. "
Finding Financing Quickly
With the British government pledging £ 20 billion to fund the NHS over the next six years, Europe is investing in health care companies under Horizon 2020 and the Food and Drug Association ( FDA). the barrier?
According to the UK NHS, two of the main barriers to managing long-term illnesses are: fragmented care and a holistic systemic approach that does not include social protection and other services; and lack of continuity of information, care records not being accessed between settings.
Funding is not mentioned for its The Care House model, although the British government has committed to providing £ 10 billion of additional capital to Parliament to invest in buildings, facilities and facilities. equipment.
In Europe, the Commission is promoting closer cooperation between regional and national authorities to stimulate the development of the health technology sector. This includes support for start-ups and small and medium-sized businesses that are developing digital solutions for person-centered care and patient feedback.
Horizon 2020 and Horizon Europe are two examples of funding resources, but they are by no means the only ones; The European Investment Bank, EIT Health and investor networks also promote digital innovation for health. This differs from the United States, where hospitals have a mix of revenue streams and health care companies rely on grants and venture capital financing.
Innovation for All
As Vandystadt noted, technology is not a major obstacle either. Abbott is an example of a medical device manufacturer with footprints around the world. Present in more than 150 countries and with more than 125 years of experience in the industry, the company has created devices to help people with diabetes, neuromodulation disorders and cardiovascular disease.
For Joel Goldsmith, senior director of digital platforms at Abbott Diabetes Care, devices mean nothing without access: "Innovation without access does not make a difference.
To be truly innovative, we must make new technologies available and accessible to all who need them. Our mission is to develop revolutionary technology that is accessible and accessible to all, because true innovation should not be an obstacle to better health.
"It all starts with giving everyone more access and control over their personal health information, so they can share it securely with other authorized stakeholders. For example, the United States is a highly developed market, but it also has a highly fragmented health care delivery system and a demanding regulatory environment. "
Resolution of fragmented data sharing
In our current health care sector, fragmentation and regulation cover the sharing of data. The health care sector has historically handled large amounts of data, but thanks to the experimental growth of wearable technologies and health applications, more personal and real-time health data is available.
According to the study mHealth App Economics 2017